Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-06

Clinical Trial Update: Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis [Phase 3]

View source ↗

Summary

Phase III trial in scalp psoriasis completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sun Pharmaceutical Industries, Inc.

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Scalp Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2018-12-06